Photo-immunotargeting with haematoporphyrin conjugates activated by a low-power He-Ne laser

Research output: Contribution to journalArticle

13 Citations (Scopus)


A combined method has been developed for selective cytolysis in vitro as well as in vivo using a photosensitizer haematoporphyrin-protein conjugate as the targeting molecule and low-power He-Ne laser (632.8 nm) irradiation in order to activate the sensitizer to its excited, toxic triplet energy state. The specificity of the procedure was demonstrated in vitro by purging a mixed cell population from one component, and in vivo in an animal (nude mice) xenograft tumour model, where human cancer cells were destroyed by the immunotargeting method using monoclonal-antibody-haematoporphyrin (mAb-HP) conjugate (a-PNAr-I mAbs, which bind to the cell surface antigens of gastric cancer cells) and soft laser irradiation. The cell destruction was dependent on the doses of both mAb-HP and He-Ne laser light energy, and occurred only in target cell populations.

Original languageEnglish
Pages (from-to)69-74
Number of pages6
JournalCancer Immunology Immunotherapy
Issue number1
Publication statusPublished - Jan 1 1992


  • Haematoporphyrin conjugates
  • He-Ne laser
  • Immunotargeting
  • Photosensitization

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Photo-immunotargeting with haematoporphyrin conjugates activated by a low-power He-Ne laser'. Together they form a unique fingerprint.

  • Cite this